24/03/2026
Continuity Biosciences and Breakthrough T1D launch a collaboration to advance a new treatment approach for type 1 diabetes
The innovative company, supported in Italy by I3P, and the global organization aim to make pancreatic islet transplantation more accessible through the NICHE platform.